Interleukin-19 ameliorates drug-induced liver injury by limiting  proinflammatory macrophage infiltration via SUMOylation of C/EBPbeta
Interleukin-19 ameliorates drug-induced liver injury by limiting proinflammatory macrophage infiltration via SUMOylation of C/EBPbeta